APOTHEEK KESTEMONT

Active

Private limited companyfounded 2006active for 20 yearsHoogstraat 23, 1930 Zaventem, BelgiumKBO/BCE: BE 0880.968.549

Summary

APOTHEEK KESTEMONT has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €800,523 and a net result of €231,908. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 59% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

APOTHEEK KESTEMONTActiveChecked score 89/100

Risk analysis Report Compare

Activity

Retail sale of pharmaceutical products

NACE 47730

1 site

Size

≈ €2.3mturnover 2025, estimated

Staff: 5.7 FTE
Equity: €800,523
Profit: €231,908

Turnover estimated from the gross margin

Financial health

89 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Structure

KESTEMONT XavierDirector

2025 accounts 73 days early1 of 2 deeds summarised

Why 89raises riskSector: Retail trade (NACE 47)lowers riskFounded in 2006Equity €800,523 (44.6% of total assets)Figures for financial year 2025 (filed 21-11-2025)Show the evidence

Checked score

Score 2025

89 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 63% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 70-3

equity 44.6% of total assets

Liquidity 47+3

short-term debt 38.6% · cash 11.9%

Profitability 85+12

return on assets 12.9%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,259 companies, NACE 47, micro)

Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.2%▲ +0.1 percentage points vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026highest value

Credit of up to €70,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.23, compared with 1.28 in 2024, below the usual 1.5; short-term debt: 38.6% and cash: 11.9% of total assets), and 55.4% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 59% on solvency, 46% on liquidity, 79% on profitability and 66% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Founded in 2006

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Equity €800,523 (44.6% of total assets)

NBB · annual accounts

Figures for financial year 2025 (filed 21-11-2025)

NBB · annual accounts

Sector: Retail trade (NACE 47)

KBO

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-11-2025, 73 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

73 days early

2024

66 days early

2023

57 days early

2022

55 days early

2021

73 days early

2020

54 days early

2019

78 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 65 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 26 November (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end29-10-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

19-11-2025 Annual accounts filedfinancial year 2025 · abbreviated…
30-06-2025 Highest result from 2019 to 2025net €231,908 ▲375%
26-11-2024 Annual accounts filedfinancial year 2024 · abbreviated…

Key points

Positive: Result rose in 2025from €48,856 to €231,908 ▲ 375% View
Positive: Among the best 10% on net resultsector median €27,714 · 12,703 companies €231,908 View
Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Positive: 7 profitable years in a rowprofit 2025: €231,908 7 years View

By topic

Financials

Financial year: 2025
Total assets: €1.8m
Profit: €231,908
Solvency: 44.6%

Total assets▲ 23.6%

Net result

20192025

Go to Financials

Board & ownership

Board: 1 member

KESTEMONT XavierDirector

Go to Board & ownership

Timeline

Events: 23
Since: 2008
Next accounts: by 31-01-2027

30-06-2024Weakest financial year
15-05-2024Resignation: KESTEMONT Xavier (manager)
05-12-2023Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Retail sale of pharmaceutical productsNACE 47730
Founded: 27-04-2006
Year ends: 30-06
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 28

Who signs: Each director alone
Annual meeting: Second Friday of November at 19:00
Purpose: “De uitbating van apotheken,de handel in en de fabricatie van scheikundige,farmaceutische…” (deed in Dutch)

Go to Articles of association

Key facts about APOTHEEK KESTEMONT

What is the company number of APOTHEEK KESTEMONT?: 0880.968.549. In Belgium the VAT number is the company number with BE in front: BE 0880.968.549.
Where is APOTHEEK KESTEMONT based?: The registered office is at Hoogstraat 23, 1930 Zaventem.Company details
What does APOTHEEK KESTEMONT do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK KESTEMONT?: Private limited company (BV).
When was APOTHEEK KESTEMONT founded?: On 27-04-2006.
Is APOTHEEK KESTEMONT still active?: Yes, APOTHEEK KESTEMONT is an active enterprise in the KBO register.
How many employees does APOTHEEK KESTEMONT have?: On average 5.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK KESTEMONT?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK KESTEMONT profitable?: In financial year 2025, APOTHEEK KESTEMONT made a profit of €231,908.
Where can I find the annual accounts of APOTHEEK KESTEMONT?: APOTHEEK KESTEMONT filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK KESTEMONT due?: By 31-01-2027, for financial year 2026.Timeline